For instance, autoantibodies to the adrenal glands were identified in APS‐1 patients and autoantibodies to NLRP5 were detected in almost 50% of APS‐1 patients with hypoparathyroidism and absent in patients without hypoparathyroidism.4 Here, NLRP5 is linked to autoimmune polyendocrine syndrome type 1.